Compare · AKUS vs NPT

AKUS vs NPT

Side-by-side comparison of Akouos Inc. (AKUS) and Texxon Holding Limited (NPT): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AKUS and NPT operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
  • NPT carries a market cap of $38.8M.
  • NPT has hit the wire 2 times in the past 4 weeks while AKUS has been quiet.
  • AKUS has more recent analyst coverage (1 ratings vs 0 for NPT).
MetricAKUSNPT
Company
Akouos Inc.
Texxon Holding Limited
Price
-
-
Market cap
-
$38.8M
1M return
-
-
1Y return
-
-
Industry
Specialty Chemicals
Specialty Chemicals
Exchange
NASDAQ
NASDAQ
IPO
2020
2025
News (4w)
0
2
Recent ratings
1
0
AKUS

Akouos Inc.

Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. Akouos, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.